Skip to main content

Scribe Therapeutics, Inc. insider trading

SCTXNASDAQ
$16.21-0.58 (-3.45% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Jul 27, 2026 to Oct 5, 2026. Price (-14.5%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • CLCarl L. GordonDirector7.1247%of company
  • ELELI LILLY & Co10% Owner5.5718%of company
  • JAJennifer A. Doudna10% Owner3.188%of company
  • BSBrett Staahl10% Owner2.7696%of company
  • BLBenjamin L. OakesPresident, CEO2.6759%of company
  • SLSvetlana LucasChief Business Officer0.0158%of company
  • DPDavid ParrotChief Financial Officer0.0141%of company
  • OAOrbimed Advisors LLCDirectorNot reportedof company
  • BABehzad AghazadehDirectorNot reportedof company
  • ABAH Bio Fund II, L.P.10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
SCTXBehzad AghazadehDirectorOpen market purchase$144K+0.3%$18.25$144KJul 28, 2026Jul 28, 2026
SCTXAH Bio Fund II, L.P.10% OwnerOpen market purchase$5M+12.1%$15.00$5MJul 27, 2026Jul 29, 2026
SCTXCarl L. GordonDirectorOpen market purchase$15M+286.7%$15.00$15MJul 27, 2026Jul 29, 2026
SCTXOrbimed Advisors LLCDirectorOpen market purchase$15M+286.7%$15.00$15MJul 27, 2026Jul 29, 2026
SCTXBehzad AghazadehDirectorOpen market purchase$1.12M+1.7%$22.31$1.12MJul 24, 2026Jul 28, 2026
SCTXBehzad AghazadehDirectorOpen market purchase$35M+334.5%$15.00$35MJul 24, 2026Jul 28, 2026
SCTXDavid ParrotChief Financial OfficerOpen market purchase$20K+100.0%$15.00$20KJul 23, 2026Jul 27, 2026
SCTXDavid ParrotChief Financial OfficerOpen market purchase$20K+100.0%$15.00$20KJul 23, 2026Jul 27, 2026
SCTXSvetlana LucasChief Business OfficerOpen market purchase$45KNot reported$15.00$45KJul 23, 2026Jul 27, 2026
End of history · 9 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.